KALA
KALA BIO, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.54
−4.53%Sep 17, 2026, 11:30 UTC
KALA BIO added Yenvy Truong, founder of The LSM Group, to its advisory team.
Source:Sep 10, 2026, 21:26 UTC
KALA BIO, Inc. signed an exclusive distribution and reseller agreement with Virotek Inc. to distribute Virotek's ophthalmology genetic testing program in the United States for an initial five-year term.
Aug 28, 2026, 00:00 UTC
KALA BIO, Inc. received a notice from NASDAQ on August 27, 2026, stating that it is not in compliance with Listing Rule 5550(a)(2) regarding the minimum bid price requirement, and the company has requested a hearing before a NASDAQ panel.